Figure 2From: A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): Rationale and design Atomoxetine dosage schedule. Week 1 is the initiation dose, with approximately 0.5 mg.kg-1 for each patient group; weeks 2-6 reach the target dose of approximately 1.2 mg.kg-1 for each group (with minimum dose of 1.0 mg.kg-1 and maximum dose of 1.4 mg.kg-1).Back to article page